Sympathetic hyper-innervation and increased levels of nerve growth factor (NGF),
Introduction
Spontaneously hypertensive rats (SHRs) and their substrain, stroke-prone SHRs (SHRSPs), exhibit sympathetic hyperinnervation of resistant vascular tissues and hypertrophy of the sympathetic ganglia, unlike their normotensive control, Wistar-Kyoto (WKY) rats (1−5) . It is thought that this increased sympathetic function contributes to the pathogenesis of hypertension in SHR-derived strains.
Nerve growth factor (NGF) has more potent neurotrophic effects on sympathetic neurons than do other neurotrophins such as brain-derived neurotrophic factor and neurotrophin-3 (6) . Interestingly, neonatal sympathectomy with anti-serum against NGF has been shown to prevent the development of hypertension in SHRs (7). Brock et al. further demonstrated that sympathectomy in SHRs with established hypertension reduced innervation by sympathetic nerves and led to a decrease in resting blood pressure (8) . Additionally, examination of NGF levels in the vasculature of developing rats revealed that NGF protein and NGF gene expression were higher in SHR than in WKY tissues (9−11) . These findings led to the hypothesis that increased NGF expression results in abnormal sympathetic neuronal function and morphology, leading to elevated blood pressure in SHR-derived strains. Kapuscinski et al. reported that the NGF gene locus was linked to blood pressure in genetic crosses of SHRs and normotensive Donryu rats based on a restriction fragment length polymorphism (RFLP) analysis of the NGF gene between these strains (12) . Furthermore, Charchar et al. reported that increased NGF gene expression also depended on the number of NGF alleles of the SHR genotype (13) . These findings led us to search for mutations within the cis-element, especially in the promoter region of the NGF gene in SHRs and SHRSPs.
In the present study, we looked for possible mutations in the cis-element of the NGF gene that might contribute to abnormal NGF function, including its increased expression in hypertensive rats. Japan. Wistar and Sprague-Dawley (SD) rats were purchased from Japan SLC, Inc. (Hamamatsu, Japan). WKY/NIH and SHRSP/NIH strains were supplied by the National Institutes of Health (NIH), Bethesda, USA.
Methods

Animals
Cloning of 5′ and 3′ Untranslated Regions (UTRs) and Coding Exon of the NGF Gene
Prior to this study, the only nucleotide sequence determined in the rat NGF gene was an approximately 650-bp-long 5′ upstream region of exon 1B, as shown in Fig. 1A (14) . Therefore, we first determined the nucleotide sequence of an approximately 4.3-kb-long SacI fragment (Fig. 1B) that was cloned from an SD rat genomic library (Clontech, Palo Alto, USA). Based on this nucleotide sequence, the following primers for the polymerase chain reaction (PCR) of genomic DNA were synthesized in order to determine the nucleotide sequences of the 5′ region of the NGF gene in the rat strains tested here: NGFP2 (5′-TTGCATGCCAGAGCTGAGAT GAAGTAGTCCTT-3′) and NGFPR (5′-TTGTCGACT GACTTTGGGACTCCTGGTCATCCT-3′). The underlined sequences were artificially added to create the SphI (NGFP2) or SalI (NGFPR) sites. The fragments of genomic DNA amplified by PCR were cloned into pGEM-3Zf(+). The genomic DNAs prepared from 3−5 rats per strain and multiple clones per strain were used to determine the nucleotide sequences.
To amplify the 3′UTR of the NGF gene by PCR of genomic DNA, NGF3′-F (5′-GCGTTGACAACAGACGACAA-3′) and NGF3′-R (5′-TGCTGAGCAGTGTCTGAAAC-3′) were used as primers, as shown in Fig. 1C . The nucleotide sequence of the 3′UTR was determined by the direct sequencing analysis method using the NGF3′-R primer. Genomic DNAs prepared from 3−5 rats per strain were used in this analysis.
The region encoding the prepro-NGF protein of the tested rat strains was cloned by reverse transcription−polymerase chain reaction (RT-PCR), as described previously (15) . The sources of the first-strand cDNAs were the total hippocampal RNAs. The primers were 5′-AAGGATCCTGGACCCAAGC TCACCTCA-3′ (forward; NGF-F) and 5′-GAGTCGACTTA CAGGCTGAGGTAGGGA-3′ (reverse; NGF-R), as shown in Fig. 1C . The underlined sequences were artificially added to create the BamHI (forward primer) or SalI (reverse primer) site. The fragments amplified by RT-PCR were cloned into pGEM-3Zf (+). Total RNAs were prepared from 3−5 rats per strain, and multiple clones per strain were used to determine the nucleotide sequences.
Assay of CAT Activity
To construct plasmids containing the NGF promoter-CAT reporter gene, two fragments (2-R and 3-R) were generated from the genomic DNAs of the SHRSP/Izm and WKY/Izm strains by PCR using the primer set NGFP2 and NGFPR or the set NGFP3 (5′-TTGCATGCAGACACAGCTCCATCT TCAACATC-3′; the underlined sequence was artificially added to create the SphI site) and NGFPR, as shown in Fig.  1B . These fragments were inserted between the SphI and SalI sites located at the 5′ side of the CAT gene in the pCAT-Basic vector (Promega, Madison, USA). COS-1 cells, which are a simian fibroblast cell line, were seeded at a density of 3 × 10 5 cells per 60-mm dish and were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) at 37°C in 5% CO2. After 24 h, the cells were transfected with 1 μg of the plasmid containing the NGF promoter-CAT reporter gene, and with c-fos and c-jun expression vector DNAs, which we constructed by insertion of human c-fos and c-jun genes, respectively, into the 3′ side of Rous sarcoma virus LTR, by using Lipofectin ® ‚ reagent (Gibco BRL, Gaithersburg, USA). After 60 h, the transfected cells were harvested and the extracts were prepared using a Reporter Lysis Buffer (Promega). The CAT activity in 25 μg protein of the cell extract was measured by the CAT Enzyme Assay System (Promega) using 1-deoxy[dichloroacetyl-1-14 C]chloramphenicol (25 kBq/ml) (Amersham Life Sciences, Arlington Heights, USA). Results obtained from the thinlayer chromatography (TLC) assay were analyzed using a MacBAS2000 imaging system (Fuji Film, Tokyo, Japan).
Linkage Analysis
We studied 108 F2 rats (male: 52; female: 56) generated from reciprocal crosses of the WKY/NIH and SHRSP/NIH strains, both of which were maintained at the University of Glasgow. Systolic blood pressure was determined by radiotelemetry in 16-week-old rats at rest in their home cages. These protocols have been described previously (16) . The DNAs of these rats were used to determine their genotypes. The genotypes were determined by nucleotide sequence analysis based on direct sequencing methods following PCR, in which the primer sets NGF3′-F and NGF3′-R were used.
Northern Blot Analysis
Vascular smooth muscle cells (VSMCs) were isolated from the thoracic aortic media of 14-week-old SHR/Izm and WKY/Izm rats, as described previously (17) . Cells were grown nearly to confluence in DMEM supplemented with 10% FCS, and then the cells were serum-starved in DMEM containing 0.5% FCS. After 48 h, the cells were treated with FCS at a final concentration of 20%. Northern blot analysis was performed using the total RNA prepared from the cells treated with serum. The hybridization was analyzed using a BAS2000 system (Fuji Film).
Determination of the Nucleotide Sequence of the 3′-Terminal Region in NGF mRNA
Total RNAs were prepared from SHR/Izm and WKY/Izm VSMCs 8 h after stimulation with serum. The RNA was then converted into cDNA with Oligo(dT)18-NotI as a primer. Then, the 3′UTR of NGF mRNA was amplified by PCR using the NGF3′-F and Oligo(dT)18-NotI as primers. The amplified fragments were digested by restriction enzymes, HincII and NotI, and then were subcloned into the BlueScriptII plasmid vector. Finally, the nucleotide sequences of those fragments were determined in multiple clones.
Results
Nucleotide Sequence of the Promoter Region of the NGF Gene in SHR, SHRSP, and Normotensive Strains
The NGF gene is composed of five exons, the last of which encodes prepro-NGF (Fig. 1A ) (18) . Although four alternative transcripts are already known, three of them include exon 1A or 1B (18) . Therefore, it has been postulated that a major functional promoter exists in the vicinity of exons 1A and 1B. The nucleotide sequence of an NGFP2-NGFPR fragment of The results revealed two differences in the upstream region of exon 1, as shown in Fig. 2A and B. The first difference was a point mutation found approximately 2.7 kb upstream from exon 1. This sequence was a G in the WKY/Izm and WKY/NIH strains, and it was an A in the SHR/Izm, SHRSP/Izm, SHRSP/NIH, Wistar, and SD strains. The other difference was a (CAAAA)x(CAA)y(A)z sequence located approximately 1.5 kb upstream from exon 1. The x and y values in the SHRderived strains were identical with those in the normotensive strains, Wistar rats and SD rats. The z value was identical among the SHR and SHRSP strains, whereas the z values in the normotensive strains differed from each other and also from that in the SHR and SHRSP strains. The y and z values in the WKY/Izm strains differed from those in the WKY/NIH strains. Therefore, the observed differences did not appear to depend on either the hypertensive or the normotensive trait.
Nucleotide Sequences of Exon 4 and the 3′UTR of the NGF Gene in SHR, SHRSP, and Normotensive Strains
We also analyzed the nucleotide sequence of exon 4, which encodes the prepro-NGF, and the 3′UTR sequence approximately 200 bp downstream from the putative poly A signal (ATTAAA) for NGF mRNA (Fig. 1C) . In the coding region for the mature NGF protein, a point mutation was found with respect to the third letter of the 182nd codon (proline) of prepro-NGF, as shown in Fig. 2C . However, no amino acid substitution resulted from this mutation. In the 3′UTR, there was a point mutation approximately 30 bp downstream from the putative poly A signal: A in the case of the WKY/Izm and WKY/NIH strains, and C in the case of the SHR/Izm, SHRSP/Izm, SHRSP/NIH, Wistar, and SD strains, as shown in Fig. 2D . Therefore, these differences did not appear to depend on either the hypertensive or the normotensive trait.
Comparison between the Promoter Activities of the SHR/SHRSP and WKY NGF Genes
The promoter activity of the SHR/SHRSP NGF gene was compared with that of the WKY gene. Two constructs containing two different fragments (2-R and 3-R) (Fig. 1B) were used for this series. Although these constructs were at first introduced solely into COS-1 cells, their CAT activity remained at a very low level (data not shown). The AP-1 transcription factor binding site (TRE; TPA response element), located in the first intron of the NGF gene (Fig. 1B) , has been reported to be essential for the transcriptional control of this gene (19) . Therefore, we measured the CAT activity in these cells after co-transfection with the expression vectors for the c-fos and c-jun genes, both of which encode components of AP-1 transcription factor (20) . The results demonstrated that Fig. 2D .
Fig. 3. Comparison of the promoter activities of the NGF genes derived from SHR/SHRSP and WKY rats. The promoter activities were estimated using extracts prepared from normal COS-1 cells (lane 1), transfectants with the WKYderived 2-R fragment-CAT reporter gene (lane 2), transfectants with the SHR/SHRSP-derived 2-R fragment-CAT reporter gene (lane 3), transfectants with the WKY-derived 3-R fragment-CAT reporter gene (lane 4), and transfectants with the SHRSP-derived 3-R fragment-CAT reporter gene (lane 5). Cm, chloramphenicol; bCm, butyrylated chloramphenicol.
Fig. 4. Relationship between genotype of the NGF gene and blood pressure in the F2 generation of SHRSP/NIH × WKY/ NIH rats. The genotypes of the F2 rats were determined by nucleotide sequence analysis of a position approximately 30 bp downstream from the putative poly A signal, as shown in
the CAT activity associated with the two constructs did not differ significantly between the SHR/SHRSP and WKY genes (Fig. 3) . We concluded that the differences between nucleotide sequences found in the promoter regions of the SHR/SHRSP and WKY NGF genes could not account for the abnormal regulation of NGF gene expression in these SHR/ SHRSP strains.
Linkage Analysis of the NGF Gene Locus and Blood Pressure
The genotypes of the NGF genes in F2-generation rats produced by crossing SHRSP/NIH × WKY/NIH rats were determined by analyzing the mutation in the 3′UTR. Figure 4 shows the relationship between the genotype of the NGF gene and blood pressure. 
Expression of the NGF, c-fos, and c-jun Genes in SHR and WKY VSMCs
The abovementioned results suggested that there is no associ- 
Nucleotide Sequences of the NGF mRNA 3′-Terminal Region in SHR and WKY VSMCs
The nucleotide sequences of the NGF mRNA 3′UTRs were determined using the RNAs prepared from the VSMCs of the SHR/Izm and WKY/Izm strains. The sequences adjacent to the poly A tail were shown to have particular patterns, and the proportion of long-mRNA species tended to be higher in the SHRs than in the WKY rats, as shown in Fig. 6 ; e.g., 6 and 11 clones in SHRs and WKY rats, respectively, had an asterisked sequence of mRNA, whereas 9 and 5 clones in SHRs and WKY rats, respectively, had a double-asterisked mRNA longer than the asterisked mRNA.
Discussion
The main aim of the present study was to search for possible mutations in the cis-element of the NGF gene that might contribute to disturbances of its expression or function, as found in SHR/SHRSP strains (9−11). Here, we analyzed the nucleotide sequences of an approximately 3-kb region upstream from exon 1, the coding exon, and the 3′UTR for the NGF gene in SHR, SHRSP, and normotensive strains. Four differences, all between the WKY and SHR/SHRSP strains, were found in these regions. However, with respect to three of these differences (the exception being (CAAAA)x(CAA)y(A)z, located in the 5′ upstream region), the nucleotide sequences of the SHR and SHRSP strains were identical with those of the normotensive strains, Wistar rats, and SD rats (Fig. 2) . As regards (CAAAA)x(CAA)y(A)z, the number of repeats were identical among the SHR and SHRSP strains, whereas the number of repeats in the normotensive strains differed from each other and also from the hypertensive strains (Fig. 2B) . Therefore, it is highly likely that these differences are polymorphisms among strains, and are not genetically responsible for the hypertension observed in SHR/SHRSP strains.
To further evaluate the abovementioned hypothesis, we measured the promoter activity of the NGF gene and estimated the association between the NGF gene locus and the elevation in blood pressure. We showed that there was no difference in promoter activity between the SHR/SHRSP and WKY genes, at least in the presence of AP-1 (Fig. 3) . One report has suggested that the NGF gene had a second promoter proximal to exon 3 (22) . Therefore, in future studies, it might be necessary to analyze the cis-element of the NGF gene in a region other than that studied here. However, our analysis of the link between blood pressure and the NGF gene locus showed no significant association between increased blood pressure and the NGF allele of the SHRSP genotype (Fig. 4) . Moreover, no significant association with sex was revealed by our analysis (data not shown). Judging from a comprehensive view of the present analyses, we considered a significant aberration within the cis-element of the NGF gene to be unlikely.
The region around the NGF gene locus is known to be a quantitative trait locus (QTL) that exerts influence on blood pressure and is located on rat chromosome 2 (16, 23−25) . The Glasgow strain used in our study has also been used to demonstrate the importance of this QTL (16) . Therefore, our linkage analysis is expected to provide important information with respect to narrowing the field of candidate QTLs. However, in their analysis of gene-segregating rats from a cross of SHR with normotensive Donryu rats, Harrap and co-workers suggested that the NGF gene locus of SHRs is linked to high blood pressure and increased NGF gene expression (12, 13) ; thus, their results are in conflict with ours. At this point in time, the reason for this contradiction remains unclear. To reach a final conclusion regarding the absence of a linkage between the NGF gene locus and hypertension, it might be essential to analyze the gene in the SHR strain used by Harrap et al. and to evaluate gene expression in the Glasgow strain used in our own study.
It is highly possible that there are some aberrations in the transcriptional factor for NGF gene expression and/or in the mechanism of the posttranscriptional regulation of protein expression from this gene, provided that a lack of any aberration within the cis-element of the NGF gene does in fact lead to an enhancement of NGF protein expression. In the present study, we also took note of the expression patterns of the c-fos and c-jun genes, both of which encode components of the AP-1 transcription factor, because this factor is believed to be centrally involved in NGF gene expression (19) . The induction of these genes by stimulation with serum in SHR VSMCs was found to be more enhanced than that in WKY VSMCs, as was also the case for the NGF gene (Fig. 5) . Touyz et al. reported that the enhanced expression of the c-fos gene by angiotensin II is higher in SHR VSMCs than in WKY VSMCs and that the overexpression of this gene is due to an extracellular signal-regulated protein kinases-dependent pathway (26) . Therefore, it will still be necessary to elucidate the mechanism for the transcriptional control of the c-fos and cjun genes in SHR/SHRSP strains in consideration of these kinases. In the present experiment, we also found that the basal level of NGF mRNA in SHR cells was lower than that in WKY cells (-48 h to 1 h in Fig. 5 ), a finding that agreed with that reported by Sherer et al. (27) . In addition, after 8 h, when NGF mRNA expression had passed its peak, the levels in SHR cells were still lower than those in WKY cells. These levels may also reveal an aberration of a trans-acting factor for NGF gene expression in SHR/SHRSP strains. We further determined the nucleotide sequences of the NGF mRNA 3′UTRs and found that the proportion of the long-mRNA spe- cies tended to be higher in SHRs than in WKY rats (Fig. 6) . The mechanism for the production of immature NGF RNA just before the addition of the poly A tail in SHRs might be different from that in WKY rats. The 3′UTR of mRNA is often involved in the stabilization of mRNA as well as in posttranscriptional regulation. The possibility of an increase in NGF mRNA stability and elevated translational efficiency has been reported in this context (27) . As shown in the present study, the production of long NGF mRNA might account for these characteristics, although such production must be validated by further analysis of a larger number of clones.
The present study indicated that there is no linkage of the NGF gene locus to the hypertensive trait of SHR/SHRSP strains. If the enhanced expression of NGF mRNA and its protein is important in the pathogenesis of the hypertension of SHR/SHRSP strains, then there must be some type of abnormality in the transcriptional and/or posttranscriptional regulation of NGF expression, apart from the abnormality in the ciselement of the NGF gene in SHR/SHRSP strains. Enhanced c-fos and c-jun gene expressions by serum-stimulation were determined here; moreover, relatively high levels of longmRNA species were observed in SHR VSMCs. Although it remains to be determined whether these events are associated with the hypertension observed in SHR/SHRSP strains, we suggest here that a locus regulating transcription and/or posttranscription might be a relatively promising site to consider for further searches for mutations that might lead to enhanced expression of NGF in rats exhibiting hypertension.
